- 
        Taxonomy & unit
      
- 
        ifrs-full: AUD
      
      - 
        Summary
      
- 
        Telix Pharmaceuticals Ltd quarterly Liabilities history and growth rate from Q4 2023 to Q4 2024.- Telix Pharmaceuticals Ltd Liabilities for the quarter ending December 31, 2024 was AUD948M, a 269% increase year-over-year.
 
 
 
  
  Liabilities, Quarterly (AUD)
  
    
  Liabilities, YoY Quarterly Growth (%)